Balachandran Madhavan 4

What Happened

• Balachandran Madhavan, a director of uniQure N.V. (QURE), exercised stock options and sold 10,000 shares. The exercise shows acquisition of 10,000 shares at $8.49 per share (total cost $84,900). Those 10,000 shares were then sold in the open market at a weighted-average price of $27.85 per share for total proceeds of $278,500. The filing also includes a derivative conversion line reported at $0, reflecting the option-to-share conversion/settlement.

Key Details

• Transaction date: June 15, 2026 (Form 4 filed June 17, 2026 — within the typical reporting window).
• Exercise: 10,000 shares acquired at $8.49 each (total $84,900).
• Sale: 10,000 shares sold in multiple trades at a weighted-average $27.85 (range $27.58–$28.05) for ~$278,500 (footnote provides per-price breakdown on request).
• Shares owned after the transaction: not specified in the information provided in this summary.
• Notable footnotes: F1 — sale executed under a pre-established Rule 10b5-1 plan (adopted March 10, 2026); F2 — weighted-average sale price and price range; F3 — the option vested in full on September 20, 2021.
• Filing timeliness: The report was filed two days after the transaction date (appears timely).

Context

• This was an option exercise followed by an immediate open-market sale (a common pattern where insiders exercise vested options and then sell shares, often under 10b5-1 plans). The exercise required cash outlay ($84.9k) and generated net proceeds from the sale ($278.5k before taxes/fees). Sales under a 10b5-1 plan are typically pre-arranged and are considered routine disclosures rather than direct signals about management’s view of the company.